These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 27523269)

  • 1. Quinacrine: A Treatment Option That Should Not Be Overlooked.
    García-Montero P; Del Boz J; Millán-Cayetano JF; de Troya-Martín M
    Actas Dermosifiliogr; 2016 Dec; 107(10):867-870. PubMed ID: 27523269
    [No Abstract]   [Full Text] [Related]  

  • 2. Chloroquine-quinacrine association in resistant cutaneous lupus.
    Lipsker D; Piette JC; Cacoub P; Godeau P; Frances C
    Dermatology; 1995; 190(3):257-8. PubMed ID: 7599397
    [No Abstract]   [Full Text] [Related]  

  • 3. The quinacrine experience in a population of patients with cutaneous lupus erythematosus and dermatomyositis.
    Mittal L; Werth VP
    J Am Acad Dermatol; 2017 Aug; 77(2):374-377. PubMed ID: 28711090
    [No Abstract]   [Full Text] [Related]  

  • 4. Practice Gaps. Optimizing antimalarial therapy for cutaneous lupus erythematosus: comment on "Response to antimalarial agents in cutaneous lupus erythematosus".
    Callen JP
    Arch Dermatol; 2011 Nov; 147(11):1267-8. PubMed ID: 22106112
    [No Abstract]   [Full Text] [Related]  

  • 5. Candidate drug replacements for quinacrine in cutaneous lupus erythematosus.
    Yan D; Borucki R; Sontheimer RD; Werth VP
    Lupus Sci Med; 2020 Oct; 7(1):. PubMed ID: 33082164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pigmented oral mucosa due to quinacrine.
    López-Jornet P; Pons-Fuster A
    N Y State Dent J; 2011 Nov; 77(6):49-51. PubMed ID: 22338819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhabdomyolysis associated with quinacrine therapy in a patient with chronic cutaneous lupus erythematosus.
    Creel N; Werth V
    J Drugs Dermatol; 2005; 4(2):225-7. PubMed ID: 15776783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yellow skin discoloration induced by quinacrine in a patient with cutaneous lupus erythematosus.
    Vidal D; Altés J; Smandia JA
    Actas Dermosifiliogr; 2013 Jan; 104(1):89-90. PubMed ID: 22831783
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of lupus skin involvement with quinacrine and hydroxychloroquine.
    Cavazzana I; Sala R; Bazzani C; Ceribelli A; Zane C; Cattaneo R; Tincani A; Calzavara-Pinton PG; Franceschini F
    Lupus; 2009 Jul; 18(8):735-9. PubMed ID: 19502270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mepacrine as successful monotherapy for refractory Jessner-Kanof disease: still an important drug in the dermatologic armamentarium.
    Wuyts L; Dandelooy J; Siozopolou V; Lambert J; Aerts O
    J Dermatolog Treat; 2017 May; 28(3):276-278. PubMed ID: 27686749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Where Should We Position Antimalarial Drug Combinations in the Management of Refractory Cutaneous Lupus Erythematosus?
    Pérez-López I; Martínez-López A; Tercedor-Sánchez J; Ruiz-Villaverde R
    Actas Dermosifiliogr; 2016; 107(6):521-2. PubMed ID: 26762693
    [No Abstract]   [Full Text] [Related]  

  • 12. Mepacrine in Recalcitrant Cutaneous Lupus Erythematosus: Old-fashioned or Still Useful?
    Benoit S; Goebeler M
    Acta Derm Venereol; 2015 May; 95(5):596-9. PubMed ID: 25474442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic discoid lupus erythematosus with quinacrine.
    RHODES BL; ALLENDE MF
    Calif Med; 1954 Feb; 80(2):70-1. PubMed ID: 13126805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lupus erythematosus treated with a combination of quinacrine, hydroxychloroquine and chloroquine.
    TYE MJ; WHITE H; APPEL B; ANSELL HB
    N Engl J Med; 1959 Jan; 260(2):63-6. PubMed ID: 13613503
    [No Abstract]   [Full Text] [Related]  

  • 15. Quinacrine hydrochloride in the treatment of lupus erythematosus.
    KIERLAND RR; BRUNSTING LA; O'LEARY PA
    Proc Staff Meet Mayo Clin; 1953 Nov; 28(22):636-40. PubMed ID: 13112265
    [No Abstract]   [Full Text] [Related]  

  • 16. Quinacrine therapy of lupus erythematosus.
    CORDERO AA; MAGNIN PH
    Prensa Med Argent; 1954 Oct; 41(42):3019-21. PubMed ID: 13236970
    [No Abstract]   [Full Text] [Related]  

  • 17. [Quinacrine hydrochlorate and vitamin B12 in the treatment of chronic lupus erythematosus].
    CORDERO AA
    Prensa Med Argent; 1953 Nov; 40(48):3238-42. PubMed ID: 13133957
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral mucosal pigmentation secondary to treatment with mepacrine, with sparing of the denture bearing area.
    Martin TJ; Sharp I
    Br J Oral Maxillofac Surg; 2004 Aug; 42(4):351-3. PubMed ID: 15225957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thalidomide therapy of cutaneous lupus erythematosus].
    Bohmeyer J; Achenbach A; Westenberger M; Stadler R
    Hautarzt; 2002 Nov; 53(11):744-8. PubMed ID: 12402138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous lupus erythematosus: update of therapeutic options part I.
    Kuhn A; Ruland V; Bonsmann G
    J Am Acad Dermatol; 2011 Dec; 65(6):e179-93. PubMed ID: 20739095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.